Lung Cancer Complicated with Interstitial Lung Diseases
Regimen N (%) AE (N) AE (%) Carboplatin + paclitaxel 140 35.4 12 8.6 Carboplatin + etoposide 82 20.7 3 3.7 Cisplatin + etoposide 38 9.6 4 10.5 Vinorelbine 30…
ONCOLOGY
ALK Mutant
© Springer Science+Business Media Singapore 2017Yuichi Takiguchi (ed.)Molecular Targeted Therapy of Lung Cancer10.1007/978-981-10-2002-5_11 11. ALK Mutant Akihiko Gemma1 (1) Division of Pulmonary Medicine, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan…
Locally Advanced Non-small Cell Lung Cancer and Targeted Therapy
Author (study name) Year Radiation (Gy/fractions) Chemotherapy N of patients Overall survival Grade 3–4 pneumonitis (%) Treatment-related death (%) Induction Concurrent Consolidation Median (month) 2y rate (%) Hallqvist A (SATELLITE)…
Small Cell Lung Cancer and Molecular Targeted Therapy
Target Agent Study phase Result References VEGF-A Bevacizumab II Promising [20] II Promising [21] II Positive for PFS, but no benefit in OS [22] VEGFR-1, VEGFR-2, VEGFR-3 Cediranib II Negative…
Next-Generation Sequencing and Bioinformatics
Fig. 6.1 Typical primary analysis pipeline of WES (a) and WTS (b). Briefly, data processing is done as follows: data cleansing, mapping to reference genome, and variant call/read counting and…
The Problem
(1) Research Oncology, Guy’s Hospital, London, United Kingdom Abstract There is substantial evidence of deleterious health behaviour in males both in terms of high-risk activities and avoidance of contact…
Clinical Features and Diagnosis
(1) Research Oncology, Guy’s Hospital, London, United Kingdom Abstract Breast cancer is rare in men and most males referred to breast clinics will have benign conditions, frequently true or…
Future Directions
(1) Research Oncology, Guy’s Hospital, London, United Kingdom Abstract A rare disease can be a source of worry for both the patient and the doctor. There is one approach…
Treatment of Advanced Disease
(1) Research Oncology, Guy’s Hospital, London, United Kingdom Abstract In many series of MBC cases the majority had stage III/IV disease at presentation and this has shown little improvement…
